FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

FDA Panel to Mull Covid Vaccine Strain Selection

FDA announces a 5/22 Vaccines and Related Biological Products Advisory Committee meeting to discuss and make recommendations on the selection of the 2...

latest-news-card-1

Michael Rogers Resigns from FDA

CBS News reports that FDA associate commissioner for inspections and investigations Michael Rogers is retiring, frustrated over changes being made by ...

latest-news-card-1
FDA General

FDA Picks Booz Allens Walsh as AI Chief

FDA taps former Booz Allen Hamilton chief technologist Jeremy Walsh to lead its artificial intelligence (AI) and information technology efforts in a n...

FDA General

Teva/Alvotechs Interchangeable Stelara Biosimilar OKd

FDA approves Teva Pharmaceuticals and Alvotechs Selarsdi injection as an interchangeable biosimilar to Janssens reference biologic Stelara (ustekinuma...

latest-news-card-1

More Unannounced Foreign Inspections Coming

FDA says it is expanding the use of unannounced inspections of foreign medical product and food manufacturing facilities.

latest-news-card-1
Human Drugs

FDA Ordered to Speed U.S. Drug Manufacturing

President Trump signs an Executive Order requiring FDA to take steps to increase domestic drug manufacturing.

latest-news-card-1
FDA General

Vinay Prasad Tapped as New CBER Director

FDA appoints University of California, San Francisco professor Vinay Prasad to serve as CBERs new director, replacing Peter Marks, who abruptly resign...

latest-news-card-1
FDA General

BIMO Inspection e-Submission Requirements Outlined

An FDA Webinar discusses drug study information in NDAs/BLAs that will need to be electronically submitted in a certain format to assist FDA in planni...

latest-news-card-1
FDA General

FDA Cancels Union Session on Layoffs

FDA cancels a scheduled meeting with the National Treasury Employees Union, which represents thousands of FDA staff, to discuss the impact of layoffs ...

latest-news-card-1
Human Drugs

RM Pharma Gains Low-Dose HemiClor Approval

FDA approves an RM Pharma 505(b)(2) for HemiClor (12.5 mg chlorthalidone) tablets for treating hypertension in adults.